La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « Toxicology »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Toxicogenetics < Toxicology < Toxin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000011 (2014) Ludmila Juricek [France] ; Xavier Coumoul [France]Alimentation, pesticides et pathologies neurologiques
000C00 (2004) Kay Castagnoli [États-Unis] ; Thangaraju Murugesan [États-Unis]Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
000C01 (2004) Moussa B. H. Youdim [Israël] ; Marta Weinstock [Israël]Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation
000C03 (2004) Michael A. Collins [États-Unis]Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler
000C19 (2004) Toshiharu Nagatsu [Japon]Progress in monoamine oxidase (MAO) research in relation to genetic engineering
000C25 (2004) William J. Burke [États-Unis] ; SHU WEN LI [États-Unis] ; Hyung D. Chung [États-Unis] ; David A. Ruggiero [États-Unis] ; Bruce S. Kristal [États-Unis] ; Eugene M. Johnson [États-Unis] ; Patricia Lampe [États-Unis] ; Vijaya B. Kumar [États-Unis] ; Mark Franko [États-Unis] ; Evelyn A. Williams [États-Unis] ; Daniel S. Zahm [États-Unis]Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
000C28 (2004) Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne]Monoamine oxidase-B inhibition in Alzheimer's disease
000C52 (2004) Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Georgy M. Nagy [Hongrie]Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains
000C60 (2004) N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France]Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus
000C64 (2004) JEAN CHEN SHIN [États-Unis]Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B
000C65 (2004) Mitsuhiko Yamada [Japon] ; Hajime Yasuhara [Japon]Clinical pharmacology of MAO inhibitors: Safety and future
000C73 (2004) Kalman Magyar [Hongrie] ; Béla Szende [Hongrie](-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Toxicology" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Toxicology" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Toxicology
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024